Q97720239

Summary

Q97720239 is an individual motion^[1].

Key Facts

• Q97720239 authored Jonas Eriksson^[2].
• Q97720239 authored Rebecka Le Moine^[3].
• Q97720239's instance of is recorded as individual motion^[4].
• Q97720239's part of the series is recorded as motions of 2018-2019 legislative session of the Riksdag^[5].
• Q97720239's language of work or name is recorded as Swedish^[6].
• Q97720239 was released on +2018-11-29T00:00:00Z^[7].
• Q97720239's main subject is medication^[8].
• Q97720239's work available at URL is recorded as http://data.riksdagen.se/dokument/H6022333^[9].
• Q97720239's work available at URL is recorded as http://data.riksdagen.se/dokumentstatus/H6022333^[10].
• Q97720239's applies to jurisdiction is recorded as Sweden^[11].
• Q97720239's legal citation of this text is recorded as Mot. 2018/19:2333^[12].
• Q97720239's title is recorded as Prisfonder för läkemedel^[13].
• Q97720239's maintained by WikiProject is recorded as Project Riksdagen's documents^[14].
• Q97720239's copyright status is recorded as public domain^[15].
• Q97720239's legislative committee is recorded as Committee on Industry and Trade^[16].

Body

Definition and Type

Q97720239's instance of is recorded as individual motion^[4].